Cover Image

Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models

The pharmacological effects of rivoglitazone, a novel thiazolidinedione-derivative peroxisome proliferator-activated receptor (PPAR)-γ agonist, were characterized in vitro and in vivo. Rivoglitazone activated human PPARγ more potently compared with rosiglitazone and pioglitazone and had little effec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shoichi Kanda (Author), Ryutaro Nakashima (Author), Kanako Takahashi (Author), Jun Tanaka (Author), Junko Ogawa (Author), Tsuneaki Ogata (Author), Makoto Yachi (Author), Kazushi Araki (Author), Jun Ohsumi (Author)
Format:	Book
Published:	Elsevier, 2009-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antidiabetic and Hypolipidemic Effects of a Novel Dual Peroxisome Proliferator-Activated Receptor (PPAR) α/γ Agonist, E3030, in db/db Mice and Beagle Dogs
by: Shunji Kasai, et al.
Published: (2008)

Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats
by: Taishi Yoshida, et al.
Published: (2011)

Molecular docking studies of α-mangostin, γ-mangostin, and xanthone on peroxisome proliferator-activated receptor gamma diphenyl peptidase-4 enzyme, and aldose reductase enzyme as an antidiabetic drug candidate
by: Rifa'atul Mahmudah, et al.
Published: (2021)

Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum
by: Lariah Edwards, et al.
Published: (2019)

Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
by: Shinji Takai, et al.
Published: (2011)

Peroxisome Proliferator-Activated Receptor γ 2 Modulates Late-Pregnancy Homeostatic Metabolic Adaptations
by: Yurena Vivas, et al.
Published: (2016)

Haplotype Analysis of Peroxisome Proliferator-activated Receptor γ Gene Polymorphisms and the Lipoprotein (a) Level
by: Chao SHEN, et al.
Published: (2018)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
by: Tamara Göbel, et al.
Published: (2019)

Estimation of peroxisome proliferators - activated receptor γ gene expression in inflammatory skin diseases: atopic dermatitis and psoriasis
by: Doaa Mahgoub, et al.
Published: (2014)

Implication of Peroxisome Proliferator-Activated Receptor γ and Proinflammatory Cytokines in Gastric Carcinogenesis: Link to Helicobacter pylori-Infection
by: Peter C. Konturek, et al.
Published: (2004)

Stereospermum tetragonam as an antidiabetic agent by activating PPARγ and GLUT4
by: Bino Kingsley, et al.
Published: (2014)

Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf
by: Mebrahtom Gebrelibanos Hiben, et al.
Published: (2020)

Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure
by: Rui Chen, et al.
Published: (2017)

Peroxisome Proliferator-Activated Receptor γ (PPARγ ) Suppresses Colonic Epithelial Cell Turnover and Colon Carcinogenesis Through Inhibition of the β-Catenin / T Cell Factor (TCF) Pathway
by: Toshio Fujisawa, et al.
Published: (2008)

Peroxisomal Disorders
by: J Gordon Millichap
Published: (1988)

Peroxisomal Disorders
by: J Gordon Millichap
Published: (1988)

Peroxisomal Disorders
by: J Gordon Millichap
Published: (1990)

Nuclear Receptors as Targets for Drug Development: Peroxisome Proliferator-Activated Receptor γ in Mast Cells: Its Roles in Proliferation and Differentiation
by: Kazutaka Maeyama, et al.
Published: (2005)

Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
by: Cao Henian, et al.
Published: (2006)

Activation of Peroxisome Proliferator-Activated Receptor γ by Rosiglitazone Inhibits Lipopolysaccharide-Induced Release of High Mobility Group Box 1
by: Jung Seok Hwang, et al.
Published: (2012)

Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation
by: Bodo Haas, et al.
Published: (2024)

The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.
by: Yuqian Luo, et al.
Published: (2020)

Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors γ degradation and inhibiting fatty acid oxidation
by: Sen‐bo Yan, et al.
Published: (2023)

Peroxisomal Disorders Diagnosis
by: J Gordon Millichap
Published: (1998)

The Activation of Peroxisome Proliferator-activated Receptor γ Enhances Insulin Signaling Pathways Via Up-regulating Chemerin Expression in High Glucose Treated HTR-8/SVneo Cells
by: Xuan Zhou, et al.
Published: (2020)

Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin / T Cell Factor (TCF) Pathway in the Mouse Intestine
by: Toshio Fujisawa, et al.
Published: (2008)

Nuclear Receptors as Targets for Drug Development: Crosstalk Between Peroxisome Proliferator-Activated Receptor γ and Cytokines in Bone Marrow-Derived Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2005)

Baohuoside I Inhibits Tumor Angiogenesis in Multiple Myeloma via the Peroxisome Proliferator-Activated Receptor γ/Vascular Endothelial Growth Factor Signaling Pathway
by: Ying Chen, et al.
Published: (2022)

Falcarindiol Purified From Carrots Leads to Elevated Levels of Lipid Droplets and Upregulation of Peroxisome Proliferator-Activated Receptor-γ Gene Expression in Cellular Models
by: Camilla Bertel Andersen, et al.
Published: (2020)

Advanced Diagnostic System and Introduction of Newborn Screening of Adrenoleukodystrophy and Peroxisomal Disorders in Japan
by: Nobuyuki Shimozawa, et al.
Published: (2021)

Danhong Inhibits Oxidized Low-Density Lipoprotein-Induced Immune Maturation of Dentritic Cells via a Peroxisome Proliferator Activated Receptor γ-Mediated Pathway
by: Hongying Liu, et al.
Published: (2012)

Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue
by: Seung Lok Ryu, et al.
Published: (2013)

The Metabolic Role of Peroxisome in Health and Disease
Published: (2022)

Antidiabetic and gastric emptying inhibitory effect of herbal Melia azedarach leaf extract in rodent models of diabetes type 2 mellitus
by: Seifu D, et al.
Published: (2017)

Procyanidin B2 enhances anti-inflammatory responses of periodontal ligament cells by inhibiting the dominant negative pro-inflammatory isoforms of peroxisome proliferator-activated receptor γ
by: Tadahiro Yamamoto, et al.
Published: (2024)

FK614, a Novel Peroxisome Proliferator-Activated Receptor γ Modulator, Induces Differential Transactivation Through a Unique Ligand-Specific Interaction With Transcriptional Coactivators
by: Takao Fujimura, et al.
Published: (2005)

Insulin Sensitization by a Novel Partial Peroxisome Proliferator-Activated Receptor γ Agonist With Protein Tyrosine Phosphatase 1B Inhibitory Activity in Experimental Osteoporotic Rats
by: Masahiro Kubo, et al.
Published: (2014)

Peroxisomal biogenesis disorders in Zellweger syndrome spectrum: diagnosis, monitoring and treatment according to the recommendations of the Global Foundation for Peroxisomal Disorders
by: M.A. Gonchar, et al.
Published: (2018)

Insulin Sensitization by PPARγ and GLUT-4 Overexpression/Translocation Mediates the Antidiabetic Effect of <i>Plantago australis</i>
by: Samuel Estrada-Soto, et al.
Published: (2023)

Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
by: Tingyan He, et al.
Published: (2023)